Form 4: Jennifer A. Doudna Reports Acquisition of Deferred Share Units in Johnson & Johnson

Director Jennifer A. Doudna reports the acquisition of deferred share units in Johnson & Johnson, to be settled in cash upon termination of directorship.

Summary

• Jennifer A. Doudna, a director of Johnson & Johnson, filed a Form 4 to report changes in beneficial ownership.
• On April 25, 2024, Doudna acquired 1,385.697 Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• These DSUs will be settled in cash upon termination of Doudna's directorship, with each DSU representing the fair market value of one share of Common Stock on the settlement date.
• Following the reported transaction, Doudna beneficially owns 8,081.638 DSUs, which includes dividend equivalent rights accrued on previously held DSUs.
• The price of each DSU at the time of acquisition was $0.0000.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing indicating standard compensation practices. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Positives

• The acquisition of DSUs reflects continued alignment of the director's interests with the long-term performance of Johnson & Johnson.
• The Deferred Fee Plan for Directors allows for deferred compensation, potentially offering tax advantages.

Future Outlook

The DSUs will be settled in cash upon termination of the Reporting Person's directorship.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's securities, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

• Shareholders are informed about the compensation structure for directors.
• The filing ensures transparency in director compensation, which can influence investor confidence.

Key Dates